An Economic Evaluation of Ranibizumab versus Aflibercept for the treatment of Neovascular (WET) AMD in the United Kingdom
May 1, 2015, 00:00 AM
10.1016/j.jval.2015.03.1057
https://www.valueinhealthjournal.com/article/S1098-3015(15)01114-6/fulltext
Section Title :
Sensory Systems Disorders
Section Order :
515
First Page :
A183
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01114-6&doi=10.1016/j.jval.2015.03.1057